IDEA $CELH ON WATCHNASDAQ:CELH
CELH looks in an interesting spot below its major long term VPA with increasing volume on weekly/monthly charts. Blue box indicates long term sell/buy zone flip which would mean it will be hard for the price to go below 25. It can break down and go towards 20- if it goes there that would be a great long term spot to add.
Buy Plan/Sell Plan
Try to open a position below $26 as possible.
If $25 breaks sell position and look to buy closer to $20.
If upside next spot where it needs to break out of $31 which is long term VPA- would look to take some profits there and see that happens
Weekly Chart
Again looks like buy/flip zone. Only thing concerning is the break below VPA which may just make it tickle down to the next volume shelf. The last few weeks./months volume did pick up which at this price level indicates buyers showing up
Monthly Chart
Again basically confirms everything in weekly
AI Info:
Financial Health and Growth:
Earnings and Revenue: Celsius Holdings reported earnings that beat analyst expectations, showing strong sales growth. The company has been expanding its market share, particularly in the energy drink sector, although there have been concerns about slower growth due to inventory adjustments with its distributor, PepsiCo.
Future Growth: The company's strategy includes international expansion and innovation in product offerings, which could drive future revenue. However, there are challenges with increased competition and the need to defend market share against giants like Monster and Red Bull.
Risks:
Market Share and Competition: Celsius has seen its market share slip slightly, with competitors gaining ground. The energy drink market is highly competitive, and Celsius needs to continue innovating to maintain and grow its market presence.
Analyst Recommendations:
Wall Street analysts have a generally bullish view on CELH. Many have given it a "Strong Buy" or "Buy" rating, with an average 12-month price target around $38.79 to $46.56, indicating significant upside potential from recent trading levels. Analysts from firms like Morgan Stanley, JP Morgan, and B.Riley have adjusted their outlook, with some lowering price targets but maintaining buy recommendations.
